Benzodiazepines in epilepsy: pharmacology and pharmacokinetics

@article{Riss2008BenzodiazepinesIE,
  title={Benzodiazepines in epilepsy: pharmacology and pharmacokinetics},
  author={J. Riss and J. Cloyd and J. Gates and S. Collins},
  journal={Acta Neurologica Scandinavica},
  year={2008},
  volume={118}
}
  • J. Riss, J. Cloyd, +1 author S. Collins
  • Published 2008
  • Medicine
  • Acta Neurologica Scandinavica
  • Benzodiazepines (BZDs) remain important agents in the management of epilepsy. They are drugs of first choice for status epilepticus and seizures associated with post‐anoxic insult and are also frequently used in the treatment of febrile, acute repetitive and alcohol withdrawal seizures. Clinical advantages of these drugs include rapid onset of action, high efficacy rates and minimal toxicity. Benzodiazepines are used in a variety of clinical situations because they have a broad spectrum of… CONTINUE READING
    361 Citations
    Antiepileptic drugs
    Benzodiazepines for prolonged seizures
    • M. Anderson
    • Medicine
    • Archives of Disease in Childhood: Education & Practice Edition
    • 2010
    • 22
    New drugs for pediatric epilepsy.
    • 31

    References

    SHOWING 1-10 OF 242 REFERENCES
    Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology.
    • J. Nelson, G. Chouinard
    • Medicine
    • The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique
    • 1999
    • 84
    Benzodiazepines in the treatment of epilepsy in people with intellectual disability.
    • 20
    Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    • G. Chouinard
    • Medicine, Psychology
    • The Journal of clinical psychiatry
    • 2004
    • 251
    Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.
    • 47
    Benzodiazepines: some aspects of their clinical pharmacology.
    • 13
    The Importance of Drug Interactions in Epilepsy Therapy
    • 383
    • PDF